Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Sponsorship Statement: This continuing medical education activity is sponsored by 
Support Statement: There is no commercial support for this activity. The content contained in this activity was developed from the Enduring Material that was supported by an educational grant from 
Target Audience: This program is designed for retina specialists, comprehensive ophthalmologists, and other healthcare professionals involved in the treatment of patients with retina disorders.
Learning Objectives: At the conclusion of this activity, participants should be able to:
- Discuss current evidence-based science on the pathogenesis of diabetic macular edema (DME) to optimize and individualize treatment regimens.
- Implement best practices for the treatment of DME based upon a thorough evaluation of ongoing clinical studies.
Faculty:
David S. Boyer, MD
Clinical Professor of Ophthalmology
University of Southern California
Keck School of Medicine
Retina-Vitreous Associates Medical Group
Los Angeles, CA
Jeffrey S. Heier, MD (Planning Committee)
Vitreoretinal Specialist
Ophthalmic Consultants of Boston
Boston, MA
Carmen A. Puliafito, MD, MBA (Planning Committee)
Retina/Vitreous Section Editor
OCULAR SURGERY NEWS
Chief Medical Editor
OSN Retina: Chief Medical Editor
RetinaCMETM.com
Dean, Keck School of Medicine
Professor of Ophthalmology
and Health Management
May S. and John Hooval Dean’s Chair in Medicine
University of Southern California
Los Angeles, California
External Reviewer:
Mitchell Goff, MD
Continuing Medical Education Information:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of release, January 1, 2012 to January 1, 2013.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the article, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 1 out of 1 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM certificate that will be e-mailed to the participant.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
David S. Boyer, MD
Consulting Fees: Alcon, Allergan, Eyetech, Genentech, Neurotech, Novartis/QLT, Pfi zer, Regeneron
Fees for Non-CME Services: Alcon, Allergan, Eyetech, Genentech, Novartis, Pfizer
Contracted Research: Alcon, Allergan, Eyetech, Genentech, Novartis, Pfi zer, Regeneron
Jeffrey S. Heier, MD (Planning Committee)
Consulting Fees: Allergan, Fovea, Genentech, Novagali, Regeneron
Contracted Research: Alimera, Allergan, Fovea, Genentech, Molecular Partners, Novagali, Regeneron
Carmen A. Puliafito, MD, MBA (Planning Committee)
Grants/Research Support: Zeiss Meditec
External Reviewer reports the following relationship(s):
Mitchell Goff, MD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2012 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.